VF Bioscience Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $201K
Latest Deal Amount
  • Investors
  • 3

VF Bioscience General Information

Description

Producer of probiotic-based food supplements intended to provide new probiotic strains, active bacterial metabolites, and fermentation products. The company's products include prevention of cardiovascular and metabolic disorders, immune system, improvement of mood and cognitive function, bone health maintenance, enabling people to healthy and tasty food supplements made out of patented plant extracts.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Specialty Chemicals
Biotechnology
Pharmaceuticals
Primary Office
  • Parc Eurasante 310 rue Jules Valles
  • 59120 Loos-lez-Lille
  • France
+33 07 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

VF Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 18-Nov-2014 $201K 00000 00000 Completed Generating Revenue
To view VF Bioscience’s complete valuation and funding history, request access »

VF Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000 000.000000 0000.00 0000.00 00 0000.00 00.000
To view VF Bioscience’s complete cap table history, request access »

VF Bioscience Patents

VF Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3093923-A1 New strains of lactic bacteria promoting calcium absorption - peptides and related products Pending 04-May-2020 0000000000
FR-3102774-A1 New strain of lactobacillus plantarum useful for intestinal calcium absorption Pending 31-Oct-2019 0000000000
FR-3094015-A1 New strains of lactic bacteria promoting calcium absorption - peptides and related products Pending 20-Mar-2019 0000000000
FR-3094014-A1 New strains of lactic bacteria promoting calcium absorption - peptides and related products Pending 20-Mar-2019 0000000000
FR-3094013-A1 New strains of lactic bacteria promoting calcium absorption - peptides and related products Pending 20-Mar-2019 A23L33/135

VF Bioscience Executive Team (2)

Name Title Board Seat Contact Info
Maxime Vaeremans Co-Founder & Chief Executive Officer
Marc Frémont Co-Founder, President and Research & Development Director
To view VF Bioscience’s complete executive team members history, request access »

VF Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VF Bioscience Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Finovam Gestion Venture Capital Minority 000 0000 000000 0
Nord France Amorçage Venture Capital Minority 000 0000 000000 0
Siparex Group PE/Buyout Minority 000 0000 000000 0
To view VF Bioscience’s complete investors history, request access »